Literature DB >> 24812136

Patient attitudes and issues in colon cancer screening.

Dayna S Early1, Darrell M Gray.   

Abstract

Colorectal cancer (CRC) is the third leading cause of cancer death in the United States, and is largely preventable by CRC screening (CRCS). Participation in CRCS, however, is much lower than participation in other forms of preventive care. Many reasons for low rates of participation have been identified, and can be generally divided into provider- and patient-specific issues. Lack of a provider recommendation is a well-established and widely reported patient barrier to CRCS. Numerous patient-specific issues have been identified, ranging from fear of CRCS test results to lack of knowledge about individual risk for CRC and inadequate resources to complete CRCS. This article discusses the impact of patient attitudes and issues toward CRCS, with particular attention to modifiable psychosocial factors, the importance of patient preferences for one CRCS test over another, knowledge of CRC risk, and the impact of educational tools on patient compliance with CRCS.

Entities:  

Mesh:

Year:  2014        PMID: 24812136     DOI: 10.6004/jnccn.2014.0071

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  3 in total

1.  On the Outskirts of National Health Reform: A Comparative Assessment of Health Insurance and Access to Care in Puerto Rico and the United States.

Authors:  Maria Portela; Benjamin D Sommers
Journal:  Milbank Q       Date:  2015-09       Impact factor: 4.911

2.  Assessment and model guided cancer screening promotion by village doctors in China: a randomized controlled trial protocol.

Authors:  Rui Feng; Xingrong Shen; Jing Chai; Penglai Chen; Jing Cheng; Han Liang; Ting Zhao; Rui Sha; Kaichun Li; Debin Wang
Journal:  BMC Cancer       Date:  2015-10-12       Impact factor: 4.430

3.  Patient participation in gastrointestinal endoscopy - From patients' perspectives.

Authors:  Hanna Dubois; Johan Creutzfeldt; Monita Törnqvist; Mia Bergenmar
Journal:  Health Expect       Date:  2020-05-05       Impact factor: 3.377

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.